PJP
Invesco Pharmaceuticals ETF
Set alert
130.54 USD +1.66 +1.29%
130.30 Day range 131.88
95.43 52-week range 131.88
- YTD
- +24.87%
- 1 year
- +36.58%
- Open
- 130.83
- Prev close
- 128.88
- Mkt cap
- 373.96M
- Vol
- 52.09K
- Avg vol
- 33.65K
- EPS
- 5.59
- P/E
- 23.35
- Div yield
- 0.00%
More statistics
- Low
- 130.30
- High
- 131.88
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 86.39
- 200-d avg
- 83.44
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 24.87
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 86.39
- 200-day average
- 83.44
About Invesco Pharmaceuticals ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
News
- Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
- Papa Johns (PJP Investments Group) Puts People at the Centre of Growth with Blink Partnership
- Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?
- Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens
- Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
- Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
- XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
- Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits
- What's Going On With Amgen Stock Tuesday?
- Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Your note
Sign in to keep a note on PJP — it syncs with the Stock Master app.